Abstract
The effects of nine central 5-HT antagonists on food intake in free feeding male rats were examined. The 5-HT2 antagonists ritanserin and ketanserin and the selective 5-HT3 antagonists ICS 205-930 and MDL 72222 had no effect on food intake. In contrast, the non-selective 5-HT antagonists metergoline, methiothepin, mesulergine, mianserin and methysergide (all of which have high affinity for various 5-HT1 receptor subtypes), dose-dependently increased food intake during a 4-h daytime test. Furthermore, metergoline dose dependently increased food intake over a 24-h period. Suprisingly, mesulergine decreased food intake over a 24-h period at the same doses that increased daytime food intake. This may indicate that the increase in daytime feeding produced by mesulergine is a non-specific response. Although the antagonists used have varying degrees of selectivity for 5-HT receptor subtypes, the pattern of results suggests that postsynaptic 5-HT1 receptors (possibly of the 5-HT1C type) play an important role in the control of feeding in rats.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Baxter MG, Miller AA, Soroko FE (1970) The effect of cyproheptadine on food consumption in the fasted rat. Br J Pharmacol 39:229–230
Beretta C, Ferrini R, Glasser AH (1965) 1-Methyl-8-β-carbobenzyloxy-aminomethyl-10 α-ergoline, a potent and long-lasting 5-hydroxytryptamine antagonist. Nature 207:421–422
Blundell JE (1977) Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes 1:15–42
Blundell JE, Leshem MB (1974) The effect of serotonin manipulations in rats with lateral hypothalamic lesions. Proc 5th International Conference on Physiology of Food and Fluid Intake, Jerusalem
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PP, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576
Buchheit KH, Costall B, Engel G, Gunning SJ, Naylor RJ, Richardson BP (1985) 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205-930 in the guinea pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in vivo. J Pharm Pharmacol 37:664–667
Chaput Y, Blier P, de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6:2796–2801
Clineschmidt BV, Hanson HM, Pflueger AB, McGuffin JC (1977) Anorexigenic and ancillary actions of MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine, CPP). Psychopharmacology 55:27–33
Coscina DV (1978) Effects of central 5,7-dihydroxytryptamine on the medial hypothalamic syndrome in rats. Ann NY Acad Sci 305:727–744
Costall B, Gunning SJ, Naylor RJ, Tyers MB (1987) The effect of GR 38032F, anovel 5-HT3-receptor antagonist on gastric emptying in the guinea pig. Br J Pharmacol 91:263–264
Dourish CT, Hutson PH, Kennett GA, Curzon G (1986) 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite [Suppl] 7:127–140
Duggan JP, Booth DA (1986) Ooesity, overeating and rapid gastric emptying in rats with ventromedial hypothalamic lesions. Science 231:609–611
Enz A (1981) Biphasic influence of an 8 alpha amino ergoline, CU 32,085 on striatal dopamine synthesis and turnover in vivo in the rat. Life Sci 29:2227–2234
Fozard JR (1984) MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36–44
Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R (1986) Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite [Suppl] 7:15–38
Goudie AJ, Thonton EW, Wheeler TJ (1976) Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and 5-hydroxy tryptophan-induced anorexia, evidence for serotoninergic inhibition of feeding. J Pharm Pharmacol 28:318–320
Graham JR (1967) Current therapeutics — methysergide. Practitioner 198:302
Heuring RE, Peroutka SJ (1987) Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–903
Hewson G, Leighton GE, Hill RG, Hughes J (1988) Ketanserin antagonizes the anoretic effect of dl-fenfluramine in the rat. Eur J Pharmacol 145:227–230
Hoebel BG, Zemlam FP, Trulson ME, Mackenzie RG, Ducret RP, Norelli C (1978) Differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine on feeding in rats. Ann NY Acad Sci 305:590–594
Hopman H (1980) Mianserin in outpatients with depressive illness in dosage up to 130 mg daily. Curr Med Res Opin [Suppl 7] 6:107–114
Hoyer D, Engel G, Kalkman HO (1985) Characterisation of the 5-HT1B recognition site in rat brain: binding studies with (-) [125I]iodocyanopindolol. Eur J Pharmacol 118:1–12
Hutson PH, Dourish CT, Curzon G (1988a) Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol 150:361–366
Hutson PH, Kennett GA, Donohoe TP, Dourish CT, Curzon G (1988b) Opposite effects of 5-HT1A and 5-HT1B/1C agonists on food intake. In: Archer T, Bevan P, Cools AR (eds) Behavioural pharmacology of 5-HT. Erlbaum, Amsterdam (in press)
Jellinger K (1982) Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32085. J Neurol 227:75–88
Kennett GA, Curzon G (1988) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137–147
Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol 141:429–435
Kilpatrick GJ, Jones BJ, Tyers MB (1987) The identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746–748
Leysen JE (1985) Serotonergic binding sites. In: Vanhoutte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York, pp 43–62
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022
Martin-Iverson MT, Dourish CT (1988) Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology (in press)
Massi M, Marini S (1987) Effect of the 5-HT2 antagonist ritanserin on food intake and on 5-HT-induced anorexia in the rat. Pharmacol Biochem Behav 26:333–340
Owen JE Jr (1963) Psychopharmacological studies of some 1-(chlorophenyl)-2-aminopropanes. I. Effects on appetite-controlled behaviour. J Pharm Sci 52:679–683
Pawlowski GJ (1975) Cyproheptadine: weight gain and appetite stimulation in essential anorexic adults. Curr Ther Res Clin Exp 18:673–678
Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539–546
Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain III. Autoradiographic mapping of serotonin-1-receptors. Neuroscience 21:97–122
Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226
Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16:687–699
Peroutka SJ, Snyder SH (1981) [3H] Mianserin: differential labelling of serotonin2 and histamine1, receptors in rat brain. J Pharmacol Exp Ther 216:142–148
Reid LR, Threlkeld PG, Wong DT (1984) Reversible reduction of food intake and body weight by chronic administration of fluoxetine. Pharmacologist 26:184
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131
Rowland NE, Carlton J (1986) Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 27:13–62
Saller CF, Stricker EM (1976) Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxtryptamine. Science 192:385–387
Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979) m-chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 308:159–163
Shor-Posner G, Grinker JA, Marmeson C, Brown O, Leibowitz SF (1986) Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull 17:663–671
Silverstone T, Goodall E (1986) Serotoninergic mechanisms in human feeding: the pharmacological evidence. Appetite [Suppl] 7:85–97
Silverstone T, Schuyler D (1975) The effect of cyproheptadine on hunger, calorie intake and bodyweight in man. Psychopharmacologia 40:335–340
Simpson RJ, Lawton DJ, Watt MH, Tiplady B (1981) Effect of zimelidine, a new antidepressant on appetite and body weight. Br J Clin Pharmacol 11:96–98
Spano PF, Biggo G, Casu M, Gessa, G., Bareggi SR, Grovini S, Trabucchi M (1978) Interaction of metergoline with striatal dopamine system. Life Sci 23:2383–2392
Sugrue MF (1987) Neuropharmacology of drugs affecting food intake. Pharmacol Ther 32:145–182
Weischer ML, Opitz K (1979) Orexigenic effects of pizotifen and cyproheptadine in cats. IRCS Med Sci 7:555
Zis AP, Fibiger HC (1975) Neuroleptic-induced deficits in food and water regulation: similarities to the lateral hypothalamic syndrome. Psychopharmacologia 43:63–68
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dourish, C.T., Clark, M.L., Fletcher, A. et al. Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats. Psychopharmacology 97, 54–58 (1989). https://doi.org/10.1007/BF00443413
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00443413